Form D · Pharmaceuticals

CHINA MEDICINE CORP

Yuexiu District , Guangzhou,, F4 · CIK 0001328790

Offering snapshot reported Jun 9, 2010 · SEC filing

Reported sold
$69.6M
Offering amount: $69.6M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 29, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$34.8M$69.6MMay 24, 2010: $69,600,000.00May 24, 2010Jun 9, 2010: $69,600,000.00Jun 9, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 9, 2010Amendment$69,600,000$0vs May 24, 20101SEC filing
May 24, 2010Initial$69,600,000No comparison1SEC filing
Feb 24, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jan 12, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$2.09M
Form D file number
021-142483
Sale of 4,000,000 shares of common stock, par value $0.0001 per share, at $3.00 per share; and 1,920,000 shares of redeemable convertible preferred stock, par value $0.0001 per share, at $30.00 per share.
As part of the expenses of the offering, Peak received a cash fee. It is also entitled to an equity fee of 232,000 shares. Issuer may be obliged to issue up to an additional 464,000 shares to Peak under certain circumstances.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Peak Capital Advisory LimitedNone

Source: Form D, filed Jun 9, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Adler Director
Yangfang Chen Director
Fred Cheung Executive
Rachel Gong Director
Minhua Liu Director, Executive
Robert Lu Executive
Ian Grant Robinson Director
Sean Shao Director
Daniel Shih Director
Ryan Shih Director
Senshan Yang Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Guangri Tower, Suite 702 No. 8 Siyou South 1 St Street
Yuexiu District , Guangzhou,, F4, 510600